ARMC
DGX icon

American Research & Management Company’s Quest Diagnostics DGX Stock Holding History

American Research & Management Company’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-200
Closed -$11K – 383
2013
Q4 		$11K Hold
200
– – ﹤0.01% 290
2013
Q3 		$12K Hold
200
– – ﹤0.01% 272
2013
Q2 		$12K Buy
+200
New +$11.9K ﹤0.01% 269

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

American Research & Management Company's DGX Position: Q1 2014 in Review

American Research & Management Company sold out of Quest Diagnostics (DGX) in Q1 2014, closing a stake of 200 shares — an estimated $11K sold.

American Research & Management Company first reported a position in DGX in Q2 2013 and held it in 3 quarters. The position peaked at $12K in Q3 2013. 491 funds tracked by Wall St. Rank hold DGX as of Q1 2014.

  • American Research & Management Company reported no remaining Quest Diagnostics position as of Q1 2014 after selling out during the quarter.
  • American Research & Management Company sold 200 Quest Diagnostics shares in Q1 2014, an estimated $11K.
  • American Research & Management Company first reported a position in Quest Diagnostics in Q2 2013 and held it in 3 quarters.
  • American Research & Management Company's Quest Diagnostics position peaked at $12K in Q3 2013.
  • 491 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2014.

Based on American Research & Management Company's 13F filing for Q1 2014, filed 14 Apr 2014.